Does PROGRAF Cause Thrombotic microangiopathy? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Thrombotic microangiopathy have been filed in association with PROGRAF. This represents 0.8% of all adverse event reports for PROGRAF.
8
Reports of Thrombotic microangiopathy with PROGRAF
0.8%
of all PROGRAF reports
4
Deaths
4
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From PROGRAF?
Of the 8 reports, 4 (50.0%) resulted in death, 4 (50.0%) required hospitalization, and 2 (25.0%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PROGRAF. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does PROGRAF Cause?
Drug ineffective (143)
Off label use (140)
Acute graft versus host disease (64)
Death (44)
Chronic graft versus host disease (43)
Renal failure (31)
Diarrhoea (30)
Pneumonia (30)
Kidney transplant rejection (29)
Malaise (27)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which PROGRAF Alternatives Have Lower Thrombotic microangiopathy Risk?
PROGRAF vs PROHANCE
PROGRAF vs PROLIA
PROGRAF vs PROMACTA
PROGRAF vs PROMAZINE
PROGRAF vs PROMETHAZINE